Orthodontic Practice Valuation in 2026: Multiples, OSO Buyers, and a Worked Example

Orthodontic practice valuation operates on a different multiple table than general dentistry, and the spread has widened every year since clear aligner technology went mainstream. A two-doctor orthodontic office in Texas doing $3.2M in collections will routinely attract written offers from three to five private equity backed OSO platforms within 30 days of going to market. A general dental practice with the same revenue will get one or two offers, and the multiple gap can be 3x to 5x EBITDA on the same dollars of cash flow.

This guide covers what drives the orthodontic premium, how the 2026 OSO buyer universe is structured, what associate compensation and real estate ownership do to your number, and a fully worked example using a two-doctor Texas practice. Every figure here reflects current 2026 deal flow, not stale multi-year averages.

How Orthodontic Practice Valuation Multiples Stack Up in 2026

Orthodontic practice valuation falls into four bands, and which band you sit in is set by doctor count, EBITDA size, and whether your practice is large enough to register as a platform acquisition rather than a tuck-in.

Single-doctor practice: 5x to 8x EBITDA. Typical EBITDA of $400K to $900K. Buyer pool is mostly individual orthodontists using a specialty practice loan or SBA 7(a), plus a handful of small OSOs running a tuck-in playbook. Headline price for a $700K EBITDA single-doc office: $4.0M to $5.6M.

Multi-doctor practice (2 to 4 producing doctors): 8x to 12x EBITDA. EBITDA of $1.2M to $3.5M. This is the sweet spot for OSO acquisitions. A multi-doctor practice with a non-owner associate carrying 30 to 50 percent of production removes single-doctor risk and triggers aggressive bidding. Headline price for a $2.5M EBITDA two-doctor practice: $22M to $30M.

Group practice (5+ locations, regional brand): 10x to 14x EBITDA. EBITDA of $4M to $10M. Strategic value emerges from shared infrastructure (lab, marketing, scheduling, IT) and proven multi-site management.

Platform-grade OSO target: 12x to 18x EBITDA. EBITDA of $8M+ across 8 or more practices with a CEO, COO, regional clinical directors, and a real central support office. Platform deals price off forward EBITDA, not trailing, because the buyer is paying for the management infrastructure that lets them bolt on tuck-ins at 6x to 8x.

The driver behind these orthodontic practice valuation bands is not just cash flow. It is the OSO arbitrage. A PE-backed OSO buys your $2.5M EBITDA practice at 10x ($25M), bolts it onto a 30-practice platform, sells the combined platform 3 to 5 years later at 14x to 16x, and captures the multiple expansion. That math only works if you sit in the multi-doctor or platform band.

What the Clear Aligner Shift Did to Orthodontic Multiples

The biggest single force behind orthodontic practice valuation multiple expansion over the past decade was the Invisalign and clear aligner shift. Three changes happened simultaneously, and each one is now baked into how OSOs underwrite a target.

First, contract value went up. Average case fee in 2010 was $4,800. In 2026, the blended average across braces and aligners is $5,800 to $7,400, with major-metro clear-aligner-heavy practices clearing $8,500 per case. Higher contract value lifts revenue per active case and lifts SDE per doctor hour.

Second, clinical time per visit dropped. Wire-bending and bracket adjustments require 30 to 45 minutes of chair time. Aligner check-ins are 10 to 20 minutes. A practice that runs 60 percent aligner cases can see 30 to 40 percent more patients per doctor day than a wire-only practice from 2008, on the same staff footprint.

Third, treatment timelines compressed. Average treatment time for an aligner case is 12 to 18 months versus 22 to 28 months for traditional braces. Shorter cases mean faster collection of contract balance, which improves cash conversion and shrinks AR aging.

Net effect on orthodontic practice valuation: SDE margins moved from a historical 28 to 35 percent range into a current 35 to 45 percent range for well-run practices. EBITDA multiples followed. A 2015 ortho practice with $2M revenue and 30 percent SDE traded at 5x to 6x SDE. The same revenue with 42 percent SDE in 2026 trades at 8x to 10x EBITDA from OSO buyers.

The flip side: practices that have not invested in scanner workflows (iTero, Trios), aligner training, or a modern PMS (Cloud9, Dolphin, OrthoTrac, topsOrtho) get marked down. Buyers assume capex of $80K to $150K per chair to bring a non-scanner practice up to current standard, and they take that off the offer.

The 2026 OSO Buyer Universe for Orthodontic Practice Valuation

The Orthodontic Support Organization landscape is more fragmented than the DSO world, and that fragmentation works in the seller’s favor. Five to eight credible OSO platforms will look at any multi-doctor practice with $1.5M+ EBITDA. Here is the active buyer set as of 2026 and the PE money behind them.

Smile Doctors. The largest pure-play OSO in the country with 400+ affiliated practices. Backed by Linden Capital from 2017, recapped by Frontier Capital in 2022, and now part of Heartland Dental, which is a KKR portfolio company. Smile Doctors typically writes the highest headline price for multi-doctor practices in Texas, Florida, Arizona, and the Carolinas, where they already have scale. Expect a 70 to 80 percent cash, 15 to 25 percent rollover equity structure, 3 to 5 year post-close clinical commitment.

OrthoDent. Backed by Audax Group since 2020. Roughly 60 affiliated practices concentrated in the Mountain West and Pacific Northwest. Aggressive on multi-doctor practices with strong associate retention.

Sage Dental. Backed by TSG Consumer Partners. Predominantly Florida and Georgia. Mixed orthodontic and general dental model. Pays well for ortho practices that fit their geographic footprint and have aligner-forward case mix.

Specialty Dental Brands. Backed by Riverside Partners. Multi-specialty platform with a dedicated orthodontic vertical. Tends to underwrite forward EBITDA more aggressively than trailing, which favors practices that have invested in new chairs or marketing in the last 12 months.

Affordable Care. Backed by Berkshire Partners. Best known for its dentures and implants brand, but the platform has been acquiring orthodontic practices since 2023 as a vertical extension play.

Beyond these five, OrthoFX, Premier Orthodontic Partners (Pamlico Capital), and several regional roll-ups round out the buyer set. The fragmentation matters: when 5 to 8 platforms are actively underwriting in the same window, a well-prepared seller will see 3 to 5 written term sheets and can run a controlled process to get the headline price 15 to 25 percent above the first verbal indication.

Associate Compensation Models and Their Impact on Orthodontic Practice Valuation

Associate doctor structure is the single largest non-financial driver of an orthodontic practice valuation outside of EBITDA. Buyers care about two things: who produces the revenue today, and who will produce it 24 months after close.

The three common associate compensation models in 2026:

• Percent of collections (28 to 32 percent). Standard for early-career associates. Predictable for the owner, scales with production. Buyers like this model because it pre-funds the post-close associate comp pool.
• Percent of production (32 to 38 percent). Used when the associate is also driving case acceptance. Slightly higher cost but easier to recruit experienced associates with portable production history.
• Base + bonus. Salary of $200K to $280K with a production bonus over a threshold. Common for second-year associates being groomed into partnership.

The buyer-side question is always: will the associate stay? An orthodontic practice valuation gets marked up 5 to 10 percent if the non-owner associate signs a transition agreement with a 24 to 36 month commitment and a geographic non-compete (10 to 25 mile radius). The same practice gets marked down 10 to 15 percent if the associate is at-will with no non-compete and verbal commitments only.

If you are the owner-doctor and you carry 80 to 100 percent of production yourself, the practice is structurally single-doctor regardless of square footage or chair count. Multiples cap in the 6x to 8x band. The fastest way to lift a valuation in the 12 to 18 months before sale is to recruit and lock in a non-owner associate carrying 25 percent or more of production.

Real Estate Ownership and Orthodontic Practice Valuation

Most orthodontic practices operate in 3,000 to 7,000 square foot single-tenant medical office buildings. Roughly 55 to 65 percent of mid-career orthodontists own the building they practice in, usually through a separate LLC that the practice pays rent to. How you handle the building at close changes the after-tax proceeds materially.

Three paths:

Sell the building concurrent with the practice. Buyer pays $400 to $700 per square foot depending on metro. A 5,000 sq ft building at $550/sq ft adds $2.75M to gross proceeds. Tax treatment is capital gains on the building, which can be favorable if your basis is low. OSO buyers will sometimes pass on real estate because they prefer asset-light expansion.

Sign a 10 to 15 year lease at fair-market rent. Rent runs $28 to $52 per square foot annually depending on geography. A 5,000 sq ft lease at $40/sq ft generates $200K of annual rental income for the seller post-close. This is the OSO-preferred path because it keeps capital free for clinical investment.

Keep the building out of the deal entirely. Sell only the practice operating entity, sign a separate market-rent lease, and reposition the building for a later 1031 exchange or hold for income. Cleanest path if the building has appreciated significantly and a 1031 into a different asset class makes sense.

The decision is rarely about valuation arithmetic alone. It is a tax and estate planning conversation, and the right answer depends on owner age, basis, holding period, and what the next chapter looks like. A buyer-side quality of earnings review usually surfaces the rent assumption baked into the EBITDA calculation, which is where this conversation starts.

ABO Certification and the Premium It Carries

The American Board of Orthodontics (ABO) certification matters more in 2026 than it did five years ago, and it carries a measurable orthodontic practice valuation premium.

Roughly 35 percent of practicing orthodontists in the U.S. are ABO-certified. Inside an OSO underwriting model, an ABO-certified owner-doctor (or associate) signals (a) clinical rigor that lowers re-do and malpractice risk, (b) marketing differentiation in a crowded metro market, and (c) credibility for case mix expansion into surgical orthodontics and complex craniofacial cases that carry higher fees.

Quantified impact: an ABO-certified practice trades at roughly 0.5x to 1.0x higher EBITDA multiple than an equivalent non-certified practice in the same band. On a $2M EBITDA practice, that is $1.0M to $2.0M of additional headline price. The certification process takes 3 to 5 years, so it is not a tactical pre-sale move, but if a non-owner associate is certified or is in the process, that should be foregrounded in the CIM.

Worked Example: Valuing a Two-Doctor Texas Orthodontic Practice

Here is a fully worked example for a two-doctor orthodontic practice valuation in suburban Texas, using current 2026 OSO buyer expectations.

Practice profile:

• Location: suburban DFW metro
• Doctors: 1 owner (52, ABO-certified), 1 associate (34, 4-year tenure, 35% of production, non-compete in place)
• Collections (TTM): $3.2M
• Case mix: 58% clear aligners, 42% braces; average contract value $6,400
• Active cases: 612
• SDE: $1.34M (42% margin)
• Building: owned by separate LLC, 5,400 sq ft, current rent paid by practice $185K/year
• PMS: Cloud9, fully digital records, 3 iTero scanners

Step 1: EBITDA normalization. Starting SDE of $1.34M. Add back owner W-2 of $420K above market replacement comp ($280K). Add back owner family-member excess comp of $48K. Add back one-time legal of $35K and one-time scanner financing payoff of $52K. Subtract market-rate associate orthodontist replacement for the owner ($280K) to convert SDE to EBITDA. Adjusted EBITDA = $1.34M + $140K + $48K + $35K + $52K – $280K = $1.335M.

Step 2: Band selection. Two-doctor practice, $1.335M EBITDA, associate retained with non-compete, ABO-certified owner, fully digital workflow. This sits cleanly in the multi-doctor band: 8x to 12x EBITDA.

Step 3: Multiple selection. Base multiple 9x for the band. Add 0.75x for ABO certification. Add 0.5x for associate retention with non-compete. Add 0.5x for aligner-forward case mix and fully digital PMS. Subtract 0.25x for DFW market competition (3 other OSO-owned practices within 8 miles). Net multiple: 10.5x.

Step 4: Headline price. $1.335M EBITDA x 10.5 = $14.02M for the practice operating entity.

Step 5: Real estate path. Owner elects to sell the building concurrent at $525/sq ft. 5,400 sq ft = $2.835M. Total gross proceeds at close: $16.86M.

Step 6: Deal structure. Smile Doctors offer arrives with 75% cash at close ($10.5M on the practice + $2.835M on the real estate = $13.35M cash), 20% rollover equity in the OSO platform ($2.8M), 5% earnout tied to 24-month EBITDA performance ($700K). Owner agrees to 4-year post-close clinical commitment at $385K/year. Associate signs new 5-year agreement with $25K equity grant.

The point of the worked example: the multiple is not a single number pulled from a chart. It is a base band, plus and minus four to six adjustments, applied to a normalized EBITDA that is itself the product of clean add-back discipline. A free dental practice valuation calculator gets you to step 3. Steps 4 through 6 require buyer-side market knowledge and a controlled process.

What to Read Next

Three guides that pair directly with orthodontic practice valuation work:

• How to buy a dental practice covers the buyer-side mechanics, useful even for sellers to understand how the other side underwrites.
• Selling a veterinary practice is the closest healthcare adjacency from a multiple and PE-rollup standpoint. The OSO playbook mirrors the veterinary corporate consolidation playbook from 2015 to 2022.
• Who buys RIAs in 2026 is useful for understanding how PE-backed roll-ups underwrite recurring revenue businesses generally, including the rollover equity and earnout structures common in OSO deals.

Before any process kicks off, a 10-minute valuation survey sets a defensible range. A 30-minute confidential call covers the buyer set actively underwriting in your metro, and a review of our PE and OSO partner network shows which platforms we have placed practices into in the last 24 months.

Frequently Asked Questions About Orthodontic Practice Valuation

What is the typical multiple for an orthodontic practice in 2026?

Orthodontic practice valuation in 2026 typically runs 5x to 8x EBITDA for single-doctor practices, 8x to 12x EBITDA for multi-doctor practices, and 12x to 18x EBITDA for platform-grade OSO acquisitions with $8M+ EBITDA across 8 or more locations. The bands have widened over the last five years as Smile Doctors, OrthoDent, Sage Dental, Specialty Dental Brands, and Affordable Care have driven competitive bidding on multi-doctor targets.

Who are the active PE-backed OSO buyers right now?

The active 2026 buyer set includes Smile Doctors (now part of Heartland Dental, a KKR portfolio company, originally backed by Linden Capital in 2017 and recapped by Frontier Capital in 2022), OrthoDent (Audax Group), Sage Dental (TSG Consumer Partners), Specialty Dental Brands (Riverside Partners), and Affordable Care (Berkshire Partners). OrthoFX and Premier Orthodontic Partners (Pamlico Capital) round out the second tier.

Why do orthodontic practices command higher multiples than general dentistry?

Three structural reasons: SDE margins of 35 to 45 percent (versus 28 to 38 percent for general dental), contracted active-case pipeline that provides 12 to 24 months of revenue floor, and active competitive bidding from 5 to 8 OSO platforms on any multi-doctor target. The clear-aligner shift compressed treatment times and lifted contract values, which pushed margins up and pulled multiples with them.

How does associate compensation affect orthodontic practice valuation?

An associate carrying 25 percent or more of production with a signed transition agreement and geographic non-compete adds 5 to 10 percent to the multiple. The same practice with an at-will associate and verbal commitments only gets marked down 10 to 15 percent. Buyers underwrite the post-close revenue base, and an associate who walks at close takes their production with them.

Should I sell the real estate concurrent with the practice?

It depends on your basis, your tax position, and the buyer. OSO platforms typically prefer to lease at fair-market rent (10 to 15 year terms, $28 to $52/sq ft) so they can keep capital free for clinical investment. Individual orthodontist buyers using SBA financing often prefer to buy the building concurrent. Selling the building adds $400 to $700/sq ft of headline proceeds; leasing it generates $150K to $300K of annual rental income post-close.

Does ABO certification actually move the valuation needle?

Yes, measurably. An ABO-certified owner-doctor or non-owner associate typically lifts the multiple by 0.5x to 1.0x EBITDA, which is $1.0M to $2.0M on a $2M EBITDA practice. The certification signals clinical rigor, lowers buyer-side re-do and malpractice risk, and supports case mix expansion into surgical orthodontics. Roughly 35 percent of practicing U.S. orthodontists are ABO-certified.

What does a typical OSO offer structure look like?

Standard OSO structure in 2026: 70 to 80 percent cash at close, 15 to 25 percent rollover equity in the OSO platform, and 5 to 10 percent earnout tied to 24-month EBITDA performance. Most OSO deals require a 3 to 5 year post-close clinical commitment from the owner-doctor at a market-rate compensation package ($350K to $450K depending on production). Earnouts tie to EBITDA growth, not revenue growth.

How long does it take to sell an orthodontic practice?

Typical timeline is 8 to 14 months from listing to close. Pre-LOI preparation (financials, active-case pipeline data, doctor production reports, associate agreements) takes 4 to 8 weeks. OSO term sheets typically arrive within 30 to 60 days of a buyer receiving a clean CIM. From signed LOI to close is 90 to 150 days, gated by quality of earnings, legal diligence, and credentialing transfer.